Jose Prieto
Infectious Disease · Brandon, FLNPI 1093748428
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $682 and has fallen 75.8% since, to $165 in 2025.
Across 101 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$333
- Melinta Therapeutics, LLC$278
- Merck$269
- Johnson & Johnson$262
- Gilead$254
- AbbVie$214
- plus $496 from 12 others
What the payments were for
- Food & beverage$2,106100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 16 | $333 |
| Melinta Therapeutics, LLC | 12 | $278 |
| Merck | 14 | $269 |
| Johnson & Johnson(2 entities) | 17 | $262 |
| Gilead | 12 | $254 |
| AbbVie(2 entities) | 10 | $214 |
| Atricure, Inc. | 1 | $125 |
| Insmed, Inc. | 4 | $85 |
| Paratek Pharmaceuticals, Inc. | 3 | $48 |
| Octapharma USA, Inc. | 2 | $46 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $43 |
| AstraZeneca | 2 | $31 |
| Shionogi Inc | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Astellas Pharma US Inc | 1 | $20 |
| Novo Nordisk | 1 | $17 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,106 in reported general payments places this provider in the 65th percentile of 669 infectious disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $64,316 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Brandon
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
- Douglas BrustMiami$359K
- Christopher CooperAltamonte Springs$278K
- Federico HinestrosaOrlando$276K
- Cynthia RiveraMiami Beach$265K
- Sally AlrabaaTampa$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.